Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

MSD Czech RepublicMSD Czech Republic
VS
Hikma PharmaceuticalsHikma Pharmaceuticals
MSD Czech Republic

MSD Czech Republic

Prague, 15000, CZ

Last Update: 28/03/2026

View Profile
Between 750 and 799
https://www.msd.cz/en/
757/1000Fair

At MSD, we harness the power of leading-edge science to save and improve lives globally. Our mission is to develop transformative therapies and vaccines that address some of the world’s most challenging health issues, including oncology, immunology, diabetology, infe...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:1,009
Subsidiaries:34
12-month incidents
0
Known data breaches
0
Attack type number
0
Hikma Pharmaceuticals

Hikma Pharmaceuticals

1 New Burlington Place, London, W1S 2HR, GB

Last Update: 12/09/2026

View Profile
Between 750 and 799
http://www.hikma.com
768/1000Fair

For almost 50 years, we’ve been creating high-quality medicines and making them accessible to the people who need them. We are a trusted, reliable partner and dependable source of over 800* high-quality generic, specialty and branded pharmaceutical products that hospita...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:10,252
Subsidiaries:0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
MSD Czech Republic

MSD Czech Republic

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Hikma Pharmaceuticals

Hikma Pharmaceuticals

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for MSD Czech Republic in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Hikma Pharmaceuticals in 2026.

Incidents

Incident History - MSD Czech Republic (X = Date, Y = Severity)

MSD Czech Republic cyber incidents detection timeline including parent company and subsidiaries.

R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Hikma Pharmaceuticals (X = Date, Y = Severity)

Hikma Pharmaceuticals cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
MSD Czech Republic

MSD Czech Republic

Incidents
No explicit notable incidents reported.
Hikma Pharmaceuticals

Hikma Pharmaceuticals

Incidents
No explicit notable incidents reported.

FAQ

Between MSD Czech Republic company and Hikma Pharmaceuticals company, which one has the best AI Cybersecurity Score ?
Between MSD Czech Republic company and Hikma Pharmaceuticals company, which one has experienced more cyber incidents in the past ?
Between MSD Czech Republic company and Hikma Pharmaceuticals company, which one has experienced more cyber incidents this year ?
Between MSD Czech Republic company and Hikma Pharmaceuticals company, which one has experienced at least one ransomware attack ?
Between MSD Czech Republic company and Hikma Pharmaceuticals company, which one has experienced at least one data breach ?
Between MSD Czech Republic company and Hikma Pharmaceuticals company, which one has experienced at least one targeted cyberattack ?
Between MSD Czech Republic company and Hikma Pharmaceuticals company, which one has experienced at least one vulnerability ?
Between MSD Czech Republic company and Hikma Pharmaceuticals company, which one holds the most compliance certifications ?
Between MSD Czech Republic company and Hikma Pharmaceuticals company, which one holds the fewest compliance certifications ?
Between MSD Czech Republic company and Hikma Pharmaceuticals company, which one has the most subsidiaries ?
Between MSD Czech Republic company and Hikma Pharmaceuticals company, which one has the largest number of employees ?
Between MSD Czech Republic and Hikma Pharmaceuticals, which company holds both SOC 2 Type 1 certifications ?
Between MSD Czech Republic and Hikma Pharmaceuticals, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - MSD Czech Republic or Hikma Pharmaceuticals ?
Which company is PCI DSS compliant - MSD Czech Republic or Hikma Pharmaceuticals ?
Between MSD Czech Republic and Hikma Pharmaceuticals, which company complies with HIPAA regulations for healthcare data ?
Between MSD Czech Republic and Hikma Pharmaceuticals, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-100739
SUMMARY

A vulnerability was detected in mathurvishal CloudClassroom-PHP-Project up to 5dadec098bfbbf3300d60c3494db3fb95b66e7be. This impacts an unknown function of the file viewresult.php. Performing a manipulation of the argument seno results in sql injection. Remote exploitation of the attack is possible. The exploit is now public and may be used. This product follows a rolling release approach for continuous delivery, so version details for affected or updated releases are not provided. The vendor was contacted early about this disclosure but did not respond in any way.

PUBLISHED
Date2026-09-26
UPDATED
Date2026-09-26
RISK INFORMATION (Score: 7.3)
CVSS2
Base Score: 7.5
Complexity: LOW
AV:N/AC:L/Au:N/C:P/I:P/A:P
CVSS3
Base Score: 7.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L
CVSS4
Base Score: 5.5
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.4
EXPLOITABILITY
3.9
REFERENCES
CVE-2026-94408
SUMMARY

Uncontrolled Resource Consumption (CWE-400) in Elasticsearch can lead denial of service via Excessive Allocation (CAPEC-130)

PUBLISHED
Date2026-09-26
UPDATED
Date2026-09-26
RISK INFORMATION (Score: 4.9)
CVSS3
Base Score: 4.9
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:N/I:N/A:H
IMPACT SCORE
3.6
EXPLOITABILITY
1.2
REFERENCES
CVE-2026-94400
SUMMARY

Uncontrolled Resource Consumption (CWE-400) in Kibana can lead denial of service via Excessive Allocation (CAPEC-130)

PUBLISHED
Date2026-09-26
UPDATED
Date2026-09-26
RISK INFORMATION (Score: 6.5)
CVSS3
Base Score: 6.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:H
IMPACT SCORE
3.6
EXPLOITABILITY
2.8
REFERENCES
CVE-2026-94399
SUMMARY

Uncontrolled Resource Consumption (CWE-400) in Elasticsearch can lead denial of service via Excessive Allocation (CAPEC-130)

PUBLISHED
Date2026-09-26
UPDATED
Date2026-09-26
RISK INFORMATION (Score: 6.5)
CVSS3
Base Score: 6.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:H
IMPACT SCORE
3.6
EXPLOITABILITY
2.8
REFERENCES
CVE-2026-94398
SUMMARY

Uncontrolled Resource Consumption (CWE-400) in Elasticsearch can lead denial of service via Excessive Allocation (CAPEC-130)

PUBLISHED
Date2026-09-26
UPDATED
Date2026-09-26
RISK INFORMATION (Score: 6.5)
CVSS3
Base Score: 6.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:H
IMPACT SCORE
3.6
EXPLOITABILITY
2.8
REFERENCES